Key result
Antihypertensive treatment in elderly patients with neurological disorders requires balancing potential cardiovascular benefits against the higher risk of adverse events such as orthostatic hypotension.
Why the study?
Most large-scale trials on elderly hypertension management have excluded patients with comorbid neurological disorders, a group where antihypertensive benefits are uncertain and adverse event risks are higher.
Managing hypertension in elderly patients with neurological comorbidities requires individualized strategies balancing cardiovascular risk reduction against adverse events like falls and orthostatic hypotension.
Optimal BP management in elderly patients with neurological comorbidities remains uncertain; leaves open the need for targeted trials.
Controlling hypertension has become an important issue in the elderly population in whom neurological comorbidities are highly prevalent. Most of the large-scale trials focusing on hypertension management in older populations have excluded patients with comorbid neurological disorders. However, this population requires special considerations, as the benefits of antihypertensive agents are mostly uncertain and there is a higher risk of adverse events. In this review article, we discuss current evidence regarding the management of elderly patients with hypertension and common neurological disorders, including stroke and neurodegenerative diseases. In elderly patient with a history of stroke, the blood pressure management strategy is generally similar to that for young patients, however the benefits of stroke prevention from blood pressure control are less significant. For patients with neurodegenerative disorders such as cognitive dysfunction and Parkinson's disease, achieving adequate blood pressure control may be beneficial in reducing cardiovascular risks, although the higher risk of adverse events from antihypertensive treatment may offset some of these benefits. Special considerations for factors such as orthostatic hypotension, risk of falls, polypharmacy, and significant drug-drug interactions are required but frequently neglected in clinical practice. More efforts are warranted to determine the optimal treatment strategy for elderly populations with neurological disorders.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) conducted a review in Elderly hypertension with neurological comorbidities. Antihypertensive treatment was evaluated. Antihypertensive treatment in elderly patients with neurological disorders requires balancing potential cardiovascular benefits against the higher risk of adverse events such as orthostatic hypotension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: